Apolipoprotein e ε4 allele and the lifetime risk of alzheimer's disease: What physicians know, and what they should know

Archives of Neurology

Volumn 52, Issue 11, 1995, Pages 1074-1079

  Seshadri, Sudha ^a   Drachman, David ^a   Lippa, Carol ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E4; APOLIPOPROTEIN E; APOLIPOPROTEIN E 4; APOLIPOPROTEIN E-4;

AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; AWARENESS; BAYES THEOREM; CONTROLLED STUDY; DEMENTIA; FAMILY HISTORY; GENETIC RISK; GENOTYPE; HUMAN; LIFE EXPECTANCY; PHYSICIAN ATTITUDE; PRIORITY JOURNAL; QUESTIONNAIRE; RISK ASSESSMENT; ADULT; GENETICS; RISK FACTOR; STATISTICAL ANALYSIS;

ACTUARIAL ANALYSIS; ADULT; AGED; ALLELES; ALZHEIMER DISEASE; APOLIPOPROTEINS E; BAYES THEOREM; HUMAN; RISK FACTORS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0028973776     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneur.1995.00540350068018     Document Type: Article

References (55)

1. Strittmatter WJ, Saunders AN, Schmechel D, et al. Apolipoprotein E: high avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer's disease. Proc Natl Acad Sci U S A. 1993;90:1977-1981.
2. Saunders AM, Strittmatter WJ, Schmechel D, et al. Association of apolipoprotein E ε4 with late-onset familial and sporadic Alzheimer's disease. Neurology. 1993;43:1462-1472.
3. Saunders AM, Schmader K, Breitner JCS, et al. Apolipoprotein E ε4 allele distributions in late-onset Alzheimer's disease and in other amyloid-forming diseases. Lancet. 1993;342:710-711.
4. Poirier J, Davignon J, Bouthillier D, Kogan S, Bertrand P, Gauthier S. Apolipoprotein E polymorphism and Alzheimer's disease. Lancet. 1993;342:697-699.
5. Mayeux R, Stern Y, Ottman R, et al. The apolipoprotein ε4 allele in patients with Alzheimer's disease. Ann Neurol. 1993;34:752-754.
6. Brousseau T, Legrain S, Berr C, Gourlet V, Vidal O, Amouyel P. Confirmation of the ε4 allele of the apolipoprotein E gene as a risk factor for late-onset Alzheimer's disease. Neurology. 1994;44:342-344.
7. Peacock ML, Fink JK. ApoE allelic association with Alzheimer's disease. Neurology. 1994;44:339-341.
8. Tsai MS, Tangalos EG, Petersen RC, et al. Apolipoprotein E: risk factor for Alzheimer disease. Am J Hum Genet. 1994;54:643-649.
9. Yu C, Payami H, Olson JM, et al. The apolipoprotein E/CI/CII gene cluster and late-onset Alzheimer disease. Am J Hum Genet. 1994;54:631-642.
10. Chartier-Harlin M, Parfitt M, Legrain S, et al. Apolipoprotein E, ε4 allele as a major risk factor for sporadic early and late-onset forms of Alzheimer's disease: analysis of the 19q13.2 chromosomal region. Hum Mol Genet. 1994;3:569-574.
11. Beardsley T. Unraveling Alzheimer's: a major cause of the disease yields to researchers. Sci Am. 1993;11:28-30.
12. Jorm AF, Korten AE, Henderson AS. The prevalence of dementia: a quantitative integration of the literature. Acta Psychiatr Scand. 1987;76:465-479.
13. Ebly EM, Parhad IM, Hogan DB, Fung TS. Prevalence and types of dementia in the very old. Neurology. 1994;44:1593-1600.
14. Weinstein MC, Fineberg HV. Clinical Decision Analysis. Philadelphia, Pa: WB Saunders Co; 1980.
15. Ben-Shlomo Y, Lewis G, McKeigue PM. Apolipoprotein E ε4 allele and Alzheimer's disease. Lancet. 1993;342:1310.
16. Van Gool WA, Hijdra A. Diagnosis of Alzheimer's disease by apolipoprotein E genotyping. Lancet. 1994;344:275.
17. Kokmen E, Beard CM, O’Brein PC, Offord MS, Kurland LT. Is the incidence of dementing illness changing? a 25-year time trend study in Rochester, Minnesota (1960-1984). Neurology. 1993;43:1887-1892.
18. Bachman DL, Wolf PA, Linn RT, et al. Incidence of dementia and probable Alzheimer's disease in a general population: The Framingham Study. Neurology. 1993;43:515-519.
19. Farrer LA, Cupples LA. Estimating the probability for major gene Alzheimer disease. Am J Hum Genet. 1994;54:374-383.
20. Sayetta RB. Rates of senile dementia-Alzheimer's type in the Baltimore longitudinal study. J Chron Dis. 1986;39:271-286.
21. Hagnell O, Franck A, Grasbeck A, et al. Senile dementia of the Alzheimer type in the Lundby study. I. Eur Arch Psychiatry Clin Neurosci. 1991;241:159-164.
22. National Center for Health Statistics. Vital Statistics of the United States, 1989: Mortality, part A. Washington, DC: Public Health Service; 1993;2(sect 1):7,10 (sect 6):7. Public Health Service publication 93-1101.
23. Lannfelt L, Lilius L, Nastase M, et al. Lack of association between apolipoprotein E allele ε4 and sporadic Alzheimer's disease. Neurosci Lett. 1994;169:175-178.
24. Corder EH, Saunders AM, Strittmatter WJ, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science. 1993;261:921-923.
25. Payami H, Kaye J, Heston LL, et al. Apolipoprotein E genotype and Alzheimer's disease. Lancet. 1993;342:738.
26. Anwar N, Lovestone S, Cheetham ME, Levy R, Powell JF. Apolipoprotein E-ε4 allele and Alzheimer's disease. Lancet. 1993;342:1308-1309.
27. Czech C, Monning U, Tienari P, et al. Apolipoprotein E-ε4 allele and Alzheimer's disease. Lancet. 1993;342:1309-1310.
28. Liddell M, Williams J, Bayer A, Kaiser F, Owen M. Confirmation of association between the ε4 allele of apolipoprotein E and Alzheimer's disease. J Med Genet. 1994;31:197-200.
29. Frisoni GB, Bianchetti A, Govoni, S et al. Association of apolipoprotein E ε4 with vascular dementia. JAMA. 1994;271:1317.
30. Kuusisto J, Koivisto K, Kervinen K, et al. Association of apolipoprotein E phenotypes with late onset Alzheimer's disease. BMJ. 1994;309:636-638.
31. Lucotte G, David F, Visvikis S, et al. Apolipoprotein E-ε4 allele and Alzheimer's disease. Lancet. 1993;342:1309.
32. Noguchi S, Murakami K, Yamada N. Apolipoprotein E genotype and Alzheimer's disease. Lancet. 1993;342:737.
33. Ueki A, Kawano M, Namba Y, Kawakami M, Ikeda K. A high frequency of apolipoprotein ε4 isoprotein in Japanese patients with late-onset nonfamilial Alzheimer's disease. Neurosci Lett. 1993;163:166-168.
34. Tsuda T, Lopez R, Rogaeva EA, et al. Are the associations between Alzheimer's disease and polymorphisms in the apolipoprotein E and the apolipoprotein C genes due to linkage disequilibrium? Ann Neurol. 1994;36:97-100.
35. Rebeck GW, Reiter JS, Strickland DK, Hyman BT. Apolipoprotein E in sporadic Alzheimer's disease. Neuron. 1993;11:575-580.
36. Nalbantoglu J, Gilfix BM, Bertrand P, et al. Predictive value of apolipoprotein E genotyping in Alzheimer's disease. Ann Neurol. 1994;36:889-895.
37. van Duijn C, de Knijff P, Cruts M, et al. Apolipoprotein ε4 allele in a population-based study of early-onset Alzheimer's disease. Nat Genet. 1994;7:74-78.
38. Okuizumi K, Onodera O, Tanaka H, et al. ApoE-ε4 and early-onset Alzheimer's. Nat Genet. 1994;7:10-11.
39. American Board of Medical Specialists. The Official ABMS Directory of Medical Specialists 1994. 26th ed. New Providence, NJ: Marquis Who's Who; 1994.
40. Cauley JA, Eichner JE, Kamboh Ml, Ferrell RE, Kuller LH. Apo E allele frequencies in younger (age 42-50) vs older (age 65-90) women. Genet Epidemiol. 1993;10:27-34.
41. Schachter F, Faure-Delanef L, Guenot F, et al. Genetic associations with human longevity at the APOE and ACE loci. Nat Genet. 1994;6:29-32.
42. Riggs JE, Keefover RW. The association between apolipoprotein E allele epsilon 4 and late-onset Alzheimer's disease. Arch Neurol. 1994;51:750.
43. Wernicke TF, Reischies FM. Prevalence of dementia in old age: clinical diagnoses in subjects aged 95 years and older. Neurology. 1994;44:250-253.
44. Drachman DA. If we live long enough, will we all be demented? Neurology. 1994;44:1563-1565.
45. Sobel E, Louhija J, Sulkava R, et al. Lack of association of apolipoprotein E allele ε4 with late-onset Alzheimer's disease among Finnish centenarians. Neurology. 1995;45:903-907
46. Rebeck GW, Perls TT, West HL, Sodhi P, Lipsitz LA, Hyman BT. Reduced apolipoprotein ε4 allele frequency in the oldest old Alzheimer's patients and cognitively normal individuals. Neurology. 1994;44:1513-1516.
47. Payami H, Montee KR, Kaye JA, et al. Alzheimer's disease, apolipoprotein ε4 and gender. JAMA. 1994;271:1316-1317.
48. Corder EH, Saunders AM, Risch NJ, et al. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nat Genet. 1994;7:180-184.
49. Smith AD, Johnson C, Sim E, et al. Protective effect of apo epsilon 2 in Alzheimer's disease. Lancet. 1994;344:473-474.
50. Talbot C, Lendon C, Craddock N, Shears S, Morris JC, Goate A. Protection against Alzheimer's disease with apoE epsilon 2. Lancet. 1994;343:1432-1433.
51. Pedro-Botet J, Senti M, Nogues X, et al. Lipoprotein and apolipoprotein profile in men with ischemic stroke. Stroke. 1992;23:1556-1562.
52. Saunders AM, Roses AD. Apolipoprotein ε4 allele frequency, ischemic cerebrovascular disease, and Alzheimer's disease. Stroke 1993;24:1416-1417.
53. Schmechel DE, Saunders AM, Strittmatter WJ, et al. Increased amyloid β-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proc Natl Acad Sci U S A. 1993;90:9649-9653.
54. Butler RN. ApoE: new risk factor for Alzheimer's. Geriatrics. 1994;49:10-11.
55. Roses AD, Strittmatter WJ, Pericak-Vance MA, Corder EH, Saunders AM, Schmechel DE. Clinical application of apolipoprotein E genotyping to Alzheimer's disease. Lancet. 1994;343:1564-1565.